FDA finds carcinogenic element in diabetes drugs

The United States Food and Drug Administration (FDA) reported that certain samples of sitagliptina compound in diabetes medications Januvia and Janumet from Merckwere contaminated with a possible carcinogen. The FDA held that it would temporarily allow Merck distribute drugs with sitagliptin containing a higher than normally acceptable amount of the …

Read More »